跳至主要内容
临床试验/NCT02042924
NCT02042924终止不适用

Pilot Study of Multi-Modality Imaging in Patients With Hematologic Malignancies

Masonic Cancer Center, University of Minnesota1 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2014年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
2
试验地点
1
主要终点
Percentage of Proliferating Bone Marrow in the Femur

研究概览

简要总结

This is a pilot sub-study of patients receiving myeloablative transplant using total body irradiation (TBI) or total marrow irradiation (TMI) in their preparative regimen. The objective of this stub-study is to estimate the heterogeneity in cellular proliferation (FLT-PET uptake) as well the heterogeneity in marrow composition distribution (measured using whole body water-fat MRI) using positron emission tomography imaging. This will be used to design future trials as well as to determine the feasibility of PET and MRI imaging.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Diagnosis of hematologic malignancy and fitting into one of the following categories:
  • •Newly diagnosed and/or day 14 post-induction chemotherapy
  • •Relapsed, including relapse after hematopoietic cell transplant
  • •Planned hematopoietic cell transplant (if enrolling at "close") or within 100 days post hematopoietic cell transplant (if enrolling post-transplant) with a preparative regimen that includes either total marrow irradiation (TMI) or total body irradiation (TBI)
  • •Undergoing natural killer cell therapies (with or without subsequent transplant)
  • •Aged 18 years and older
  • •Not pregnant - women of childbearing potential will have a confirmatory pregnancy test prior to each imaging per routine procedures
  • •Adequate renal function (estimated glomerular filtration rate > 60 ml/min) as determined by a serum creatinine level performed as a part of standard of care within 7 days of imaging
  • •Able and willing to provide written consent

排除标准

  • •Otherwise eligible patients meeting one or more of the contraindicates for an MRI, may enroll in the study without undergoing the MRI:
  • •ferromagnetic implants
  • •history of shrapnel or shot gun injury
  • •too large to fit in the magnet (approximate body mass index ≥ 40)
  • •cardiac pacemakers or other implanted devices that are not MR-compatible
  • •claustrophobia
  • •large tattoos

研究组 & 干预措施

Imaging studies

Experimental

Subjects will have a FLT PET/CT and a MRI prior to starting the preparative regimen for transplant and another of each scan 100 days after transplant.

干预措施: FLT PET/CT (Radiation)

Imaging studies

Experimental

Subjects will have a FLT PET/CT and a MRI prior to starting the preparative regimen for transplant and another of each scan 100 days after transplant.

干预措施: MRI (Device)

结局指标

主要结局

Percentage of Proliferating Bone Marrow in the Femur

时间窗: 100 days

The difference in the percentage of proliferating bone marrow between baseline and day 100 post transplant in the femur

Difference in Percentage of Proliferating Bone Marrow Between Baseline and 100 Days

时间窗: 100 days

The difference in percentage of proliferating bone marrow will be calculated for the following sites: skull, proximal humeri, ribs, clavicles, cervical spine, thoracic spine, lumbar spine, sacrum, pelvis and proximal femur.

Difference in Water Fat

时间窗: 100 days

The difference in the water-fat MRI between baseline and day 100 post transplant in L4 and femoral neck.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验